Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

scynexis logo

Categories Won:

  1. Quality

  2. Reliability

  3. Regulatory

  4. Productivity

  5. Innovation

 

Drug Life Cycle Stages:

  • Research & Development: Discovery, Preclinical
  • Drug Substance Production: Primary Process Development, Drug Substance Production

Main Service Areas:
Preclinical

Services & Capabilities:
Process development: novel chemistries, small & nonsmall molecules, bioactive lipids, glycolipids;  cGMP manufacture; analytical control of processes: impurity identification characterization, method  development, phaseappropriate validation, ICH stability, final product release

Therapeutic Areas:
We have provided our expertise and support across multiple therapeutic areas. A few examples include  but are not limited to: CNS, inflammation, antiinfectives, etc.

Dr. Yves Ribeill

CEO

“At SCYNEXIS we deliver innovative solutions that complement our  customers’ capabilities. Our expert team understands the drug  development path and consistently delivers high-quality GMP material while meeting customer timelines. Being recognized in these categories is a reflection of our high standards of safety, quality, and GMP compliance. Our GMP facility has been FDA inspected twice with no 483 issued. It’s a pleasure to see our expertise recognized by our peers.”